🇺🇸 FDA
Patent

US 10745416

Macrocyclic compounds for treating disease

granted A61PA61P35/00

Quick answer

US patent 10745416 (Macrocyclic compounds for treating disease) held by TURNING POINT THERAPEUTICS, INC. expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNING POINT THERAPEUTICS, INC.
Grant date
Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P35/00